| Total (N = 583) |
Consult Setting Inpatient Outpatient |
10/558 (1.8%) 548/558 (98.2%) |
Hospitalization for facilitating diabetes treatment change | 3/547 (0.5%) |
Reason for changing First Line Therapy | |
Lack of Efficacy | 549 (94.2%) |
Hypoglycemic Event | 25 (4.3%) |
Weight Gain | 54 (9.3%) |
Side Effect | 21 (3.6%) |
Developed Acute Disease | 2 (0.3%) |
Developed Chronic Disease | 2 (0.3%) |
Affordability | 0 (0.0%) |
Inability to Self-administer | 5 (0.9%) |
Patient Request | 13 (2.2%) |
Poor adherence | 17 (2.9%) |
Patient convenience | 7 (1.2%) |
Prescriber access reasons | 1 (0.2%) |
Drug interaction | 0 (0.0%) |
Physician preference | 9 (1.5%) |
Reason for Choosing a Second-Line Therapy | |
Efficacy | 508 (87.1%) |
Tolerability | 190 (32.6%) |
Weight | 152 (26.1%) |
Hypoglycemic | 130 (22.3%) |
Patient request | 28 (4.8%) |
Convenience | 37 (6.3%) |
Access Reason | 4 (0.7%) |
Cost | 48 (8.2%) |
Other | 9 (1.5%) |